PEREGRINE PHARMACEUTICALS IN's ticker is PPHMXXXX and the CUSIP is 713661304. A total of 74 filers reported holding PEREGRINE PHARMACEUTICALS IN in Q3 2013. The put-call ratio across all filers is 0.30 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2017 | $18,000 | -10.0% | 30,000 | 0.0% | 0.00% | – |
| Q1 2017 | $20,000 | +122.2% | 30,000 | 0.0% | 0.00% | – |
| Q4 2016 | $9,000 | -30.8% | 30,000 | -3.1% | 0.00% | – |
| Q3 2016 | $13,000 | +18.2% | 30,944 | -0.1% | 0.00% | – |
| Q2 2016 | $11,000 | -15.4% | 30,980 | +3.3% | 0.00% | – |
| Q1 2016 | $13,000 | -62.9% | 30,000 | 0.0% | 0.00% | – |
| Q4 2015 | $35,000 | +12.9% | 30,000 | 0.0% | 0.00% | – |
| Q3 2015 | $31,000 | -20.5% | 30,000 | 0.0% | 0.00% | – |
| Q2 2015 | $39,000 | -4.9% | 30,000 | 0.0% | 0.00% | – |
| Q1 2015 | $41,000 | +57.7% | 30,000 | +58.9% | 0.00% | – |
| Q3 2013 | $26,000 | -83.6% | 18,880 | -84.6% | 0.00% | – |
| Q2 2013 | $159,000 | – | 122,979 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| BAXTER BROS INC | 170,506 | $232,000 | 0.09% |
| First Heartland Consultants, Inc. | 86,204 | $117,000 | 0.05% |
| Rotella Capital Management, Inc. | 20,769 | $28,000 | 0.03% |
| FIDGEON TIMOTHY F | 33,000 | $45,000 | 0.02% |
| QS BATTERYMARCH FINANCIAL MANAGEMENT, INC | 547,800 | $746,000 | 0.02% |
| Freedom Investment Management, Inc. | 74,127 | $101,000 | 0.02% |
| Investors Capital Advisory Services | 63,288 | $86,000 | 0.02% |
| REYNOLDS CAPITAL MANAGEMENT LLC | 10,000 | $14,000 | 0.01% |
| Tower Research Capital LLC (TRC) | 76,914 | $104,000 | 0.01% |
| PINNACLE FINANCIAL PARTNERS INC | 20,000 | $27,000 | 0.01% |